Observational Study of HeartMate 3® Device Data
This observational study, called "Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future," is looking at information from the HeartMate 3® left ventricular assist device (LVAD) in patients. Researchers will connect this device data with real-world health conditions like frailty, GI bleeds, right heart failure, and infections. The goal is to better understand how the device works in patients and predict potential problems. You may be able to join if you are 18 years or older and are scheduled to receive a HeartMate 3® dLVAD. The main thing they are looking at is how long patients survive after 12 months. This study is currently unclear about its recruitment status and plans to include about 150 participants.
- Study design
- This is an observational study, meaning researchers will analyze existing data from the HeartMate 3® device and patient health records. It aims to enroll about 150 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Survival will be measured at 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
At a glance
Conditions
NCT06039176
Where you'd take part
This study runs at 7 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Mayo Clinic-Rochester
Rochester, Minnesotano site contact published
Recruiting
UCSF
San Francisco, Californiano site contact published
Recruiting
University of Chicago
Chicago, Illinoisno site contact published
Recruiting
University of Florida
Gainesville, Floridano site contact published
Recruiting
MUSC
Charleston, South Carolinano site contact published
Active, not recruiting
University of Kansas Medical Center
Kansas City, Kansasno site contact published
Active, not recruiting
University of Utah
Salt Lake City, Utahno site contact published
Active, not recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Sarah E Schroeder, PhD MSN RN · PRINCIPAL_INVESTIGATOR · International Consortium of Circulatory Assist Clinicians
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Survival12-months
12-month survival post LVAD implantation stratified by percentage of abnormal pump data